Brompton Global Healthcare Income & Growth ETF (HIG.TO) focuses on generating income and capital appreciation through investments in global healthcare equities. The ETF primarily invests in companies involved in pharmaceuticals, biotechnology, and healthcare services, leveraging the growing demand for healthcare solutions across developed and emerging markets.
The ETF generates income through dividends from its portfolio of healthcare stocks, while also seeking capital appreciation through strategic investments in high-growth healthcare companies. Its competitive advantage lies in its specialized focus on the healthcare sector, which is less correlated with economic cycles, providing a defensive investment option.
Changes in healthcare regulations impacting profitability
Market performance of underlying healthcare equities
Interest rate fluctuations affecting dividend attractiveness
Global healthcare spending trends
Regulatory changes affecting drug pricing and healthcare access
Technological disruption in healthcare delivery
Increased competition from other healthcare-focused ETFs
Market volatility impacting healthcare stock valuations
Liquidity risks associated with market downturns
Potential for increased management fees impacting net returns
moderate - The healthcare sector is generally resilient during economic downturns, but significant recessions can still impact spending.
Rising interest rates may lead to lower demand for dividend-paying stocks as fixed income investments become more attractive, potentially compressing valuations.
minimal
dividend - Investors seeking income through dividends and stability in their portfolios.
moderate - Historically, healthcare equities exhibit moderate volatility compared to broader market indices.